ALPHA TRIBE

Aurobindo Pharma LimitedUpdates, 12-12-2025: General Updates

12-12-2025 | 05:12 pm

Aurobindo Pharma's subsidiary, Apitoria Pharma, received 3 procedural observations on a Form 483 following a US FDA inspection of its API manufacturing facility. The company clarifies this development has no impact on operations.

No comments yet. Be the first to comment!

All announcements from Aurobindo Pharma Limited